QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
OTCMKTS:FSNUY

Fresenius SE & Co. KGaA - FSNUY Stock Forecast, Price & News

$7.23
-0.04 (-0.55%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$7.19
▼
$7.49
50-Day Range
$6.62
▼
$7.75
52-Week Range
$4.79
▼
$10.99
Volume
32,703 shs
Average Volume
31,188 shs
Market Capitalization
$16.29 billion
P/E Ratio
8.82
Dividend Yield
2.23%
Price Target
$39.34
FSNUY stock logo

About Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Stock

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Stock News Headlines

January 20, 2023 | msn.com
Healthcare workers union petitions FDA to recall Fresenius dialysis machines
January 2, 2023 | finance.yahoo.com
Fresenius SE KGaA (ETR:FRE) shareholders have endured a 57% loss from investing in the stock five years ago
February 6, 2023 | Investing Trends (Ad)
New "Vertical" Technology Solves Solar Power's Major Flaw
Even conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.
December 22, 2022 | marketwatch.com
With 3.3% CAGR, Hemodialysis & Peritoneal Dialysis Market to Witness A Pronounce Growth During 2023-2028 | 104 Pages Report
December 16, 2022 | finance.yahoo.com
Painful week for individual investors invested in Fresenius SE & Co. KGaA (ETR:FRE) after 3.3% drop, institutions also suffered losses
December 6, 2022 | msn.com
FMC gets new CEO after parent Fresenius flags business review
December 6, 2022 | msn.com
UPDATE 4-FMC boss leaves after two months as Fresenius pushes for changes
December 5, 2022 | bloomberg.com
Fresenius Dialysis Unit CEO to Leave Over Strategic Differences
February 6, 2023 | Investing Trends (Ad)
New "Vertical" Technology Solves Solar Power's Major Flaw
Even conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.
December 2, 2022 | finance.yahoo.com
Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?
November 29, 2022 | finance.yahoo.com
Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?
November 21, 2022 | theglobeandmail.com
$FME : Fresenius Medical Care Enters Monthly Buying Area
November 21, 2022 | uk.finance.yahoo.com
COMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius SE EUR 3.5yr & 7yr
November 21, 2022 | markets.businessinsider.com
EQS-AFR: Fresenius SE & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
November 9, 2022 | finance.yahoo.com
Fresenius SE KGaA Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
November 8, 2022 | markets.businessinsider.com
Fresenius Medical Care North America Named Among 100 Healthiest Workplaces
November 4, 2022 | markets.businessinsider.com
Fresenius Medical Care North America Announces FDA Clearance of New Heat Purification System for Hemodialysis Water with Industry-Leading Efficiency
October 31, 2022 | seekingalpha.com
Fresenius SE & Co. KGaA (FSNUF) Q3 2022 Earnings Call Transcript
October 31, 2022 | msn.com
Fresenius cuts guidance again amid macroeconomic pressures and struggling North American unit
October 31, 2022 | finance.yahoo.com
Fresenius Cuts 2022 Views on Worse Outlook for FMC; 3Q Earnings Fell Sharply
October 25, 2022 | finance.yahoo.com
Fresenius CEO signals realignment, confirms call with Elliott - FAZ newspaper
October 12, 2022 | seekingalpha.com
Fresenius cut to Hold at Jefferies citing staffing issues and inflation
October 10, 2022 | finance.yahoo.com
The deal that showed Musk how hard it would be to exit Twitter bid
October 8, 2022 | markets.businessinsider.com
Fresenius Medical Care Named to Newsweek's 100 Most Loved Workplaces for Second Consecutive Year
October 6, 2022 | benzinga.com
Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient
October 5, 2022 | reuters.com
Fresenius taps pre-dialysis kidney care as drugs promise treatment change
September 6, 2022 | benzinga.com
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
See More Headlines
Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Company Calendar

Last Earnings
5/06/2021
Today
2/06/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:FSNUY
CUSIP
N/A
CIK
N/A
Web
www.fresenius.com
Phone
(496) 172-6080
Fax
N/A
Employees
316,078
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$39.34
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
+444.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
12 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.82
Trailing P/E Ratio
8.82
Forward P/E Ratio
8.61
P/E Growth
N/A
Net Income
$2.15 billion
Net Margins
4.17%
Pretax Margin
8.74%
Return on Equity
5.58%
Return on Assets
2.32%

Debt

Debt-to-Equity Ratio
0.58
Current Ratio
1.32
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$44.39 billion
Price / Sales
0.37
Cash Flow
$2.39 per share
Price / Cash Flow
3.03
Book Value
$15.51 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
2,252,950,000
Free Float
N/A
Market Cap
$16.29 billion
Optionable
Not Optionable
Beta
1.10

Social Links


Key Executives

  • Michael Sen
    Chief Executive Officer
  • Sara Hennicken
    Chief Financial Officer
  • Rice Powell
    Chief Executive Officer-Fresenius Medical Care
  • Francesco de Meo
    Chief Executive Officer-Fresenius Helios
  • Ernst Wastler
    Chief Executive Officer-Fresenius Vamed

Key Competitors

View All Competitors













FSNUY Stock - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last twelve months. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FSNUY shares.
View FSNUY analyst ratings or view top-rated stocks.

What is Fresenius SE & Co. KGaA's stock price forecast for 2023?

12 Wall Street analysts have issued 1-year target prices for Fresenius SE & Co. KGaA's stock. Their FSNUY share price forecasts range from $24.00 to $87.00. On average, they predict the company's stock price to reach $39.34 in the next year. This suggests a possible upside of 441.2% from the stock's current price.
View analysts price targets for FSNUY or view top-rated stocks among Wall Street analysts.

How have FSNUY shares performed in 2023?

Fresenius SE & Co. KGaA's stock was trading at $6.99 at the beginning of 2023. Since then, FSNUY shares have increased by 4.0% and is now trading at $7.27.
View the best growth stocks for 2023 here.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 66,200 shares, an increase of 57.2% from the December 31st total of 42,100 shares. Based on an average trading volume of 75,800 shares, the days-to-cover ratio is presently 0.9 days.
View Fresenius SE & Co. KGaA's Short Interest.

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its earnings results on Thursday, May, 6th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. The company earned $10.83 billion during the quarter. Fresenius SE & Co. KGaA had a trailing twelve-month return on equity of 5.58% and a net margin of 4.17%.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.23%. The dividend payout ratio is 19.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FSNUY will have a dividend payout ratio of 18.39% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FSNUY.

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $7.27.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) has a market capitalization of $16.38 billion and generates $44.39 billion in revenue each year. The company earns $2.15 billion in net income (profit) each year or $0.82 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

The company employs 316,078 workers across the globe.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The official website for the company is www.fresenius.com. The company can be reached via phone at (496) 172-6080 or via email at ir-fre@fresenius.com.

This page (OTCMKTS:FSNUY) was last updated on 2/6/2023 by MarketBeat.com Staff